A review of the therapeutic management of Crohn's disease.

Ther Adv Gastroenterol · 2022 · PMC8859667 · PMID 35198041

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

42 The results were borderline significant at 1 year (4% vs 25%) and was not significant at 2 (26% vs 43%) and 3 years (30% vs 50%) after resection; however, this may be due to the small sample size rather than clear lack of benefit from metronidazole.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.